PODD vs. DXCM

Last updated Apr 1, 2026

Compare and contrast key facts about Insulet Corporation (PODD) and DexCom, Inc. (DXCM).

Performance

PODD vs. DXCM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Insulet Corporation (PODD) and DexCom, Inc. (DXCM). The values are adjusted to include any dividend payments, if applicable.

PODD vs. DXCM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
PODD Insulet Corporation	-26.18%	8.88%	20.32%	-26.30%	10.64%	4.08%	49.32%	115.83%	14.96%	83.12%
DXCM DexCom, Inc.	-5.38%	-14.66%	-37.33%	9.58%	-15.64%	45.23%	69.02%	82.59%	108.75%	-3.87%

Fundamentals

Market Cap PODD : $14.83B DXCM : $25.05B
EPS PODD : $3.50 DXCM : $2.07
PE Ratio PODD : 60.00 DXCM : 30.40
PEG Ratio PODD : 0.06 DXCM : 0.72
PS Ratio PODD : 5.47 DXCM : 5.45
PB Ratio PODD : 9.79 DXCM : 9.12
Total Revenue (TTM) PODD : $2.71B DXCM : $4.66B
Gross Profit (TTM) PODD : $1.94B DXCM : $2.80B
EBITDA (TTM) PODD : $456.00M DXCM : $1.34B

Returns By Period

In the year-to-date period, PODD achieves a -26.18% return, which is significantly lower than DXCM's -5.38% return. Over the past 10 years, PODD has outperformed DXCM with an annualized return of 20.13%, while DXCM has yielded a comparatively lower 14.02% annualized return.

PODD

• 1D: 0.88%
• 1M: -14.91%
• YTD: -26.18%
• 6M: -32.03%
• 1Y: -20.09%
• 3Y*: -13.03%
• 5Y*: -4.55%
• 10Y*: 20.13%

DXCM

• 1D: 1.45%
• 1M: -14.48%
• YTD: -5.38%
• 6M: -6.67%
• 1Y: -8.04%
• 3Y*: -18.54%
• 5Y*: -7.23%
• 10Y*: 14.02%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

PODD vs. DXCM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PODD

PODD Risk / Return Rank: 21
PODD Sharpe Ratio Rank: 19
PODD Sortino Ratio Rank: 18
PODD Omega Ratio Rank: 19
PODD Calmar Ratio Rank: 28
PODD Martin Ratio Rank: 21

DXCM

DXCM Risk / Return Rank: 34
DXCM Sharpe Ratio Rank: 34
DXCM Sortino Ratio Rank: 31
DXCM Omega Ratio Rank: 32
DXCM Calmar Ratio Rank: 37
DXCM Martin Ratio Rank: 37

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PODD vs. DXCM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Insulet Corporation (PODD) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	PODD	DXCM	Difference
Sharpe ratio Return per unit of total volatility	-0.51	-0.18	-0.33
Sortino ratio Return per unit of downside risk	-0.60	0.04	-0.63
Omega ratio Gain probability vs. loss probability	0.93	1.01	-0.08
Calmar ratio Return relative to maximum drawdown	-0.46	-0.19	-0.27
Martin ratio Return relative to average drawdown	-1.14	-0.38	-0.77
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

PODD vs. DXCM - Sharpe Ratio Comparison

The current PODD Sharpe Ratio is -0.51, which is lower than the DXCM Sharpe Ratio of -0.18. The chart below compares the historical Sharpe Ratios of PODD and DXCM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	PODD	DXCM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.51	-0.18	-0.33
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.11	-0.16	+0.05
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.48	0.29	+0.19
Sharpe Ratio (All Time) Calculated using the full available price history	0.29	0.29	0.00

Correlation

The correlation between PODD and DXCM is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

PODD vs. DXCM - Dividend Comparison

Neither PODD nor DXCM has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

PODD vs. DXCM - Drawdown Comparison

The maximum PODD drawdown since its inception was -90.28%, roughly equal to the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for PODD and DXCM.

Drawdown Indicators

	PODD	DXCM	Difference
Max Drawdown Largest peak-to-trough decline	-90.28%	-94.61%	+4.33%
Max Drawdown (1Y) Largest decline over 1 year	-41.04%	-38.75%	-2.29%
Max Drawdown (5Y) Largest decline over 5 years	-61.31%	-66.32%	+5.01%
Max Drawdown (10Y) Largest decline over 10 years	-61.31%	-66.32%	+5.01%
Current Drawdown Current decline from peak	-40.52%	-61.43%	+20.91%
Average Drawdown Average peak-to-trough decline	-24.64%	-35.79%	+11.15%
Ulcer Index Depth and duration of drawdowns from previous peaks	16.53%	19.27%	-2.74%

Volatility

PODD vs. DXCM - Volatility Comparison

Insulet Corporation (PODD) has a higher volatility of 10.42% compared to DexCom, Inc. (DXCM) at 9.22%. This indicates that PODD's price experiences larger fluctuations and is considered to be riskier than DXCM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PODD	DXCM	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.42%	9.22%	+1.20%
Volatility (6M) Calculated over the trailing 6-month period	24.33%	27.63%	-3.30%
Volatility (1Y) Calculated over the trailing 1-year period	39.49%	43.67%	-4.18%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	42.04%	46.76%	-4.72%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	42.20%	48.31%	-6.11%

Financials

PODD vs. DXCM - Profitability Comparison

The chart below illustrates the profitability comparison between Insulet Corporation and DexCom, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

PODD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Insulet Corporation reported a gross profit of 568.60M and revenue of 783.80M. Therefore, the gross margin over that period was 72.5%.

DXCM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, DexCom, Inc. reported a gross profit of 792.70M and revenue of 1.26B. Therefore, the gross margin over that period was 62.9%.

PODD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Insulet Corporation reported an operating income of 146.30M and revenue of 783.80M, resulting in an operating margin of 18.7%.

DXCM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, DexCom, Inc. reported an operating income of 323.00M and revenue of 1.26B, resulting in an operating margin of 25.6%.

PODD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Insulet Corporation reported a net income of 101.60M and revenue of 783.80M, resulting in a net margin of 13.0%.

DXCM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, DexCom, Inc. reported a net income of 267.30M and revenue of 1.26B, resulting in a net margin of 21.2%.